Influence of the PPAR-γ2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects

被引:33
作者
Ostergård, T
Ek, J
Hamid, Y
Saltin, B
Pedersen, OB
Hansen, T
Schmitz, O
机构
[1] Aarhus Univ Hosp, Aarhus Sygehus, Dept Med Endocrinol & Diabet M, DK-8000 Aarhus, Denmark
[2] Univ Aarhus, Dept Clin Pharmacol, Aarhus, Denmark
[3] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[4] Hagedorn Res Inst, DK-2820 Gentofte, Denmark
[5] Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark
关键词
polymorphism; type; 2; diabetes; exercise; insulin resistance;
D O I
10.1055/s-2005-861174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aerobic endurance training improves insulin sensitivity, and is of great importance in the prevention and treatment of type 2 diabetes. The improvement in insulin sensitivity and cardiovascular function through exercise is highly variable among individuals, and is probably partly determined by genetic components. This study evaluated the peroxisome proliferation-activated receptor-gamma 2 (PPAR-gamma 2) Pro12Ala polymorphism and the angiotensin converting enzyme (ACE) I/D polymorphism with respect to any potential influence that these highly prevalent polymorphisms may impose on changes in insulin sensitivity and maximal aerobic capacity induced by exercise. Seventy-nine healthy first-degree relatives of type 2 diabetic patients were compared to a control group consisting of 54 subjects without any family history of type 2 diabetes. All subjects had a normal OGTT. The groups were comparable with respect to age (34 +/- 7 vs. 33 +/- 7 years), gender ((m/f) 43/36 vs. 30/24) and BMI (25.7 +/- 2.6 vs. 25.3 +/- 2.5 kg/m(2)); p (all) = NS. Furthermore, a subgroup of 29 offspring and 17 controt subjects were engaged in a standardized training program lasting ten weeks. Insulin sensitivity (hyperinsulinemic euglycemic clamp technique) and VO(2)max (exhaustive exercise test) was assessed before and after the training period. We will demonstrate the allelic frequency of the Ala-allele of the Pro12Ala polymorphism to be lower in offspring to type 2 diabetic patients (13.3%) compared to control subjects (21.3%); p < 0.05. In offspring only, the Pro12Ala polymorphism of the PPAR-gamma 2 gene appeared to enhance weight changes brought about by exercise (Delta weight = -0.3 +/- 1.4 kg vs. - 1.8 +/- 1.8 kg; p < 0.05; (Pro/Pro vs. Pro/Ala + Ala/Ala) - suggesting possible gene-environment or gene-gene interactions. The ACE I/D polymorphism was not of significant importance in determining the capability of responding to exercise in terms of improvement in insulin sensitivity or maximal aerobic capacity.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 50 条
  • [21] The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes
    Lapice, Emanuela
    Monticelli, Antonella
    Cocozza, Sergio
    Pinelli, Michele
    Cocozza, Sara
    Bruzzese, Dario
    Riccardi, Gabriele
    Vaccaro, Olga
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [22] Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population
    Meshkani, Reza
    Taghikhani, Mohammad
    Larijani, Bagher
    Bahrami, Yadollah
    Khatami, Shohreh
    Khoshbin, Ehteram
    Ghaemi, Amir
    Sadeghi, Sedigheh
    Mirkhani, Fatemeh
    Molapour, Azam
    Adeli, Khosrow
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (04) : 477 - 482
  • [23] The minor allele of the PPARγ2 Pro12Ala polymorphism is associated with lower postprandial TAG and insulin levels in non-obese healthy men
    Helwig, Ulf
    Rubin, Diana
    Kiosz, Julia
    Schreiber, Stefan
    Foelsch, Ulrich R.
    Nothnagel, Michael
    Doering, Frank
    Schrezenmeir, Juergen
    BRITISH JOURNAL OF NUTRITION, 2007, 97 (05) : 847 - 854
  • [24] Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism
    Rubin, Diana
    Herrmann, Julia
    Much, Daniela
    Pfeuffer, Maria
    Laue, C.
    Winkler, P.
    Helwig, Ulf
    Bell, Doris
    Auinger, Annegret
    Darabaneanu, Stephanie
    Ruether, Andreas
    Schrezenmeir, Juergen
    GENES AND NUTRITION, 2012, 7 (04) : 499 - 509
  • [25] Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism
    Diana Rubin
    Julia Herrmann
    Daniela Much
    Maria Pfeuffer
    C. Laue
    P. Winkler
    Ulf Helwig
    Doris Bell
    Annegret Auinger
    Stephanie Darabaneanu
    Andreas Ruether
    Jürgen Schrezenmeir
    Genes & Nutrition, 2012, 7 : 499 - 509
  • [26] The PPARγ2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy
    Jorsal, A.
    Tarnow, L.
    Lajer, M.
    Ek, J.
    Hansen, T.
    Pedersen, O.
    Parving, H. -H.
    MOLECULAR GENETICS AND METABOLISM, 2008, 94 (03) : 347 - 351
  • [27] Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians
    Ek, J
    Andersen, G
    Urhammer, SA
    Hansen, L
    Carstensen, B
    Borch-Johnsen, K
    Drivsholm, T
    Berglund, L
    Hansen, T
    Lithell, H
    Pedersen, O
    DIABETOLOGIA, 2001, 44 (09) : 1170 - 1176
  • [28] A personalised diet approach study: Interaction between PPAR-γ Pro12Ala and dietary insulin indices on metabolic markers in diabetic patients
    Abaj, Faezeh
    Rafiee, Masoumeh
    Koohdani, Fariba
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2022, 35 (04) : 663 - 674
  • [29] In vitro effect of PPAR-γ2 Pro12Ala polymorphism on the deposition of Alzheimer's amyloid-β peptides
    d'Abramo, Cristina
    Zingg, Jean-Marc
    Pizzuti, Antonio
    Argellati, Francesca
    Pronzato, Maria A.
    Ricciarelli, Roberta
    BRAIN RESEARCH, 2007, 1173 : 1 - 5
  • [30] Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy
    Chen, Yung-Nien
    Wang, Pei-Wen
    Tung, Shih-Chen
    Kuo, Ming-Chun
    Weng, Shao-Wen
    Chou, Chen-Kai
    Chang, Chih-Min
    Tsa, Chia-Jen
    Taso, Cheng-Feng
    Shen, Feng-Chih
    Chen, Jung-Fu
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (04) : 923 - 929